Aileen Wang
Directeur Financier/CFO chez CLOVER BIOPHARMACEUTICALS, LTD.
Postes actifs de Aileen Wang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur Financier/CFO | 01/07/2022 | - |
| Corporate Officer/Principal | 01/03/2021 | - |
Historique de carrière de Aileen Wang
Anciens postes connus de Aileen Wang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - | - |
Formation de Aileen Wang
| The Pennsylvania State University | Masters Business Admin |
| Shanghai Jiao Tong University | Undergraduate Degree |
Statistiques
Internationale
| Chine | 3 |
| Etats-Unis | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Bourse
- Insiders
- Aileen Wang
- Expérience